Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Tobramycin (liposomal)

EU orphan designation number: EU/3/06/366
Active ingredient: Tobramycin (liposomal)
Indication: Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis
Sponsor: Axentis Pharma Limited
Carpenter Court, 1 Maple Road, Bramhall, Stockport, Cheshire SK7 2DH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/04/2006 Orphan designation EMEA/OD/112/05 (2006)1643 of 11/04/2006
31/10/2008 Transfer of orphan designation EMEA/OD/112/05/T/01 (2008)6528 of 29/10/2008
27/02/2013 Removal of orphan designation from Community Register